BamSEC and AlphaSense Join Forces
Learn More

Vanda Pharmaceuticals Inc. – Material Contracts

NASDAQ: VNDA    
Share price (5/22/26): $6.19    
Market cap (5/22/26): $372 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 5 pages Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan: Notice of Performance Restricted Stock Unit Award
12/34/56
EX-10.1
from 10-Q 7 pages Amendment No. 7 to Lease
12/34/56
EX-10.1
from S-8 21 pages Vanda Pharmaceuticals Inc. 2016 Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 5 pages Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan: Notice of Restricted Stock Unit Award
12/34/56
EX-10.1
from S-8 20 pages Vanda Pharmaceuticals Inc. 2016 Equity Incentive Plan
12/34/56
EX-10.47
from 10-K 54 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Normally Treats as Private and Confidential. Such Excluded Information Has Been Marked “[***]”. Asset Purchase Agreement by and Between Actelion Pharmaceuticals Ltd. and Vanda Pharmaceuticals Inc. Dated as of December 7, 2023
12/34/56
EX-10.8
from 10-Q 9 pages Uk Sub-Plan to the Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan Notice of Stock Option Grant
12/34/56
EX-10.7
from 10-Q 5 pages Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan Notice of Stock Option Grant
12/34/56
EX-10.6
from 10-Q 6 pages Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan Notice of Stock Option Grant
12/34/56
EX-10.5
from 10-Q 5 pages Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan Notice of Stock Option Grant
12/34/56
EX-10.4
from 10-Q 7 pages Uk Sub-Plan to the Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan: Notice of Restricted Stock Unit Award
12/34/56
EX-10.3
from 10-Q 3 pages Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan: Notice of Restricted Stock Unit Award
12/34/56
EX-10.2
from 10-Q 5 pages Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan: Notice of Restricted Stock Unit Award
12/34/56
EX-10.1
from 10-Q 5 pages Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan: Notice of Restricted Stock Unit Award
12/34/56
EX-10.2
from 10-Q 5 pages Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan: Notice of Restricted Stock Unit Award
12/34/56
EX-10.1
from 10-Q 5 pages Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan: Notice of Restricted Stock Unit Award
12/34/56
EX-10.1
from S-8 18 pages Vanda Pharmaceuticals Inc. 2016 Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 23 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is of the Type That Vanda Treats as Private or Confidential. Such Excluded Information Has Been Marked With “[***].” License Agreement
12/34/56
EX-10.29
from 10-K 69 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is of the Type That Vanda Treats as Private or Confidential Manufacturing Agreement May 6, 2016
12/34/56
EX-10.12
from 10-K 62 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is of the Type That Vanda Treats as Private or Confidential Manufacturing Agreement January 24, 2014
12/34/56